We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

Theratechnologies

Community Affairs Manager: Renee Connolly

Email: cdesrochers@theratech.com

Telephone Number: 514-336-4804, ext. 239

Drugs in Pre-approval Status:

1) Tesamorelin — growth hormone-releasing factor

Comment: Phase II and Phase III data presented and published. Approval anticipated third or fourth quarter, 2009 (to be sold and marketed in U.S. by EMD Serono).